✦ LIBER ✦

Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes

✍ Scribed by J.-P. Courrèges; T. Vilsbøll; M. Zdravkovic; T. Le-Thi; T. Krarup; O. Schmitz; R. Verhoeven; I. Bugáñová; S. Madsbad

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The once-daily human glucagon-like pepti

✍ Anne Flint; Christoph Kapitza; Charlotte Hindsberger; Milan Zdravkovic 📂 Article 📅 2011 🏛 Springer Healthcare Communications 🌐 English ⚖ 238 KB

Liraglutide, a once-daily human glucagon

✍ A. Garber; R. R. Henry; R. Ratner; P. Hale; C. T. Chang; B. Bode 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 971 KB

Improved glycaemic control with minimal

✍ K. Kaku; M. F. Rasmussen; P. Clauson; Y. Seino 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 595 KB

Patient-reported rating of gastrointesti

✍ M. Horowitz; T. Vilsbøll; M. Zdravkovic; M. Hammer; S. Madsbad 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

Weight loss with liraglutide, a once-dai

✍ J. Jendle; M. A. Nauck; D. R. Matthews; A. Frid; K. Hermansen; M. Düring; M. Zdr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

Liraglutide, a once-daily human GLP-1 an

✍ T. Vilsbøll; B. Brock; H. Perrild; K. Levin; H.-H. Lervang; K. Kølendorf; T. Kra 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB